Inhibits NNMT, elevates NAD+, enhances fatty acid oxidation, reduces fat accumulation and lipotoxicity
Thats why the FDAs own technical staff has recommended against expanded access, and the public health group Partnership for Safe Medicines calls them "popular, unproven, dangerous. As Peter Kolchinsky, managing partner of biotech investor RA Capital Management, puts it: Is the FDA going to stand on science or is it going to permit all kinds of snake oil to be readily available? The FDA meeting will last two days
A planned Phase I safety trial of 42 healthy volunteers receiving oral BPC-157 was conducted in 2015, but results were never formally published following cancellation of planned submission in 2016
Some people notice results in days
Keep in a cool, dry place away from direct sunlight